Lycored’s Lumenato to be deemed a Novel Food by the EFSA
The carotenoid-rich nutraceutical has been proven to support skin health by protecting it from UV exposure and collagen degradation
There’s a lot to look forward to.
Due to successful results in the first phase of our study on the effects of our Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project.
May 19, 2016
Testing our products to prove clinical efficacy is one of our core values, and something that sets us apart in the industry. Due to successful results in the first phase of our study on the effects of our Lycored Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project. The results of the study showed that subjects who ingested our blend had significantly reduced systolic and diastolic blood pressures and increased retinal capillary blood flow markers. Professor Alon Harris, principal clinical study investigator, believes that “these initial results of the […] study showcase the importance of the development of supplements for eyes and where the future of the vision health industry is heading.” We hope to keep the promising results coming, and we’re excited to see what phase two brings.
Continue reading
Lumenato™ Receives EFSA Approval, Expanding Market Availability
The FDA and HHS formalizes plans to phase out synthetic colors
On April 22nd, the FDA announced in a press release its intention to phase out petroleum-based synthetic dyes in food, beyond Red 3. While industry actors seem to be divided...
We're here for you
Interested in speaking directly with a member of our team?
Click below to get in touch.